{
    "clinical_study": {
        "@rank": "122902", 
        "acronym": "BMC2012", 
        "arm_group": {
            "arm_group_label": "BMC2012", 
            "arm_group_type": "Experimental", 
            "description": "The large bone defect was then be bridged as per clinical standard, filled with a clinically established scaffold (\u00df-TCP), and 1.3 x106/ml BMC were loaded per 1 ml \u00df-TCP in situ."
        }, 
        "brief_summary": {
            "textblock": "In the present phase-I clinical trial we investigate safety and feasibility of an\n      augmentation with preoperatively isolated autologous BMC cells seeded onto \u00df-TCP in\n      combination with an angle stable fixation (Philos plate\u00ae) for the therapy of proximal\n      humeral fractures."
        }, 
        "brief_title": "Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial", 
        "condition": "Humerus Fracture Displaced Proximal", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Humeral Fractures", 
                "Shoulder Fractures"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients aged between 50. and 90. years with proximal humerus fractures\n\n          -  indication for open reposition and internal stabilisation with a proximal fixed-\n             angle plate for humerus (PHILOS, Synthes, Oberdorf, Swiss):\n\n          -  2-, 3- or 4-fragment fracture according to NEer\n\n          -  dislocation of >10 mm between fragments and/or\n\n          -  angle of > 45\u00b0 between fragments and/or\n\n          -  dislocation of tuberculum major > 5 mm\n\n          -  negative pregnancy test of premenopausal women\n\n          -  signed informed consent for surgery and participation in the clinical trial\n\n        Exclusion Criteria:\n\n          -  contraindications against administration of Investigational medicinal product (IMP)\n             is pregnancy and nursing\n\n          -  dislocation fracture\n\n          -  known psychic disorder that leads to incompliance (e.g. dementia, schizophrenia,\n             major depression)\n\n          -  pathologic fractures caused by other underlying diseases\n\n          -  fracture-induced nerve damage\n\n          -  tumor disease with recent adjuvant therapy or treatment during the last 3 months\n             (e.g. chemotherapy, radiotherapy), untreated tumor diseases\n\n          -  known hypersensibility against components of the transplant\n\n          -  participation in a clinical trial during the last 3 months prior to this study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02153372", 
            "org_study_id": "BMC2012"
        }, 
        "intervention": {
            "arm_group_label": "BMC2012", 
            "intervention_name": "BMC2012", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "large bone defect, bone marrow-derived mononuclear cells", 
        "lastchanged_date": "May 29, 2014", 
        "location": {
            "contact": {
                "email": "marzi@trauma.uni-frankfurt.de", 
                "last_name": "Ingo Marzi, MD Prof.", 
                "phone": "00496963016123"
            }, 
            "contact_backup": {
                "email": "ccseebach@googlemail.com", 
                "last_name": "Caroline Seebach, MD Ph.D.", 
                "phone": "00496963017110"
            }, 
            "facility": {
                "address": {
                    "city": "Frankfurt", 
                    "country": "Germany", 
                    "state": "Theodor-Stern-Kai 7", 
                    "zip": "60590"
                }, 
                "name": "Department of trauma-, hand- and reconstructive surgery, Goethe University Hospital"
            }, 
            "investigator": {
                "last_name": "Ingo Marzi, MD Prof.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "Cell Based Therapy by Implanted Bone Marrow-derived Mononuclear Cells (BMC) for Bone Augmentation of Plate-stabilized Proximal Humeral Fractures", 
        "other_outcome": [
            {
                "description": "Analysis of fracture healing, consolidation, necrosis, dislocation of reposition, screw cutting", 
                "measure": "osseous healing  by radiologic evaluation", 
                "safety_issue": "No", 
                "time_frame": "at day 0"
            }, 
            {
                "description": "testing the function of the shoulder", 
                "measure": "DASH-Score", 
                "safety_issue": "No", 
                "time_frame": "at 12 weeks post surgery"
            }, 
            {
                "description": "analysis of medication and Adverse Events", 
                "measure": "documentation of concomitant medication and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "at day -1"
            }, 
            {
                "description": "Analysis of fracture healing, consolidation, necrosis, dislocation of reposition, screw cutting", 
                "measure": "osseous healing  by radiologic evaluation", 
                "safety_issue": "No", 
                "time_frame": "week 1 post surgery"
            }, 
            {
                "description": "Analysis of fracture healing, consolidation, necrosis, dislocation of reposition, screw cutting", 
                "measure": "osseous healing  by radiologic evaluation", 
                "safety_issue": "No", 
                "time_frame": "week 6 post surgery"
            }, 
            {
                "description": "Analysis of fracture healing, consolidation, necrosis, dislocation of reposition, screw cutting", 
                "measure": "osseous healing  by radiologic evaluation", 
                "safety_issue": "No", 
                "time_frame": "week 12 post surgery"
            }, 
            {
                "description": "analysis of medication and Adverse Events", 
                "measure": "documentation of concomitant medication and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "day 0"
            }, 
            {
                "description": "analysis of medication and Adverse Events", 
                "measure": "documentation of concomitant medication and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "week 1"
            }, 
            {
                "description": "analysis of medication and Adverse Events", 
                "measure": "documentation of concomitant medication and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "week 6 post surgery"
            }, 
            {
                "description": "analysis of medication and Adverse Events", 
                "measure": "documentation of concomitant medication and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "week 12 post surgery"
            }
        ], 
        "overall_contact": {
            "email": "marzi@trauma.uni-frankfurt.de", 
            "last_name": "Ingo Marzi, MD Prof.", 
            "phone": "00496963016123"
        }, 
        "overall_contact_backup": {
            "email": "ccseebach@googlemail.com", 
            "last_name": "Caroline Seebach, MD Ph.D.", 
            "phone": "00496963017110"
        }, 
        "overall_official": {
            "affiliation": "Department of Trauma-, hand- and reconstructive surgery, Goethe University, Frankfurt", 
            "last_name": "Ingo Marzi, MD Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Paul-Ehrlich-Institut", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Analysis of safety :  morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein,      Interleukin-6, procalcitonin) fever (> 38,5\u00b0C longer than 2 days)", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "at day -1"
            }, 
            {
                "description": "Analysis of safety :  morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein,      Interleukin-6, procalcitonin) fever (> 38,5\u00b0C longer than 2 days)", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "at day 0"
            }, 
            {
                "description": "Analysis of safety :  morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein,      Interleukin-6, procalcitonin) fever (> 38,5\u00b0C longer than 2 days)", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "week 1 post surgery"
            }, 
            {
                "description": "Analysis of safety :  morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein,      Interleukin-6, procalcitonin) fever (> 38,5\u00b0C longer than 2 days)", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "week 6 post surgery"
            }, 
            {
                "description": "Analysis of safety :  morbidity of bone marrow punction local reaction (infection, delayed wound healing) systemic reaction (leucocytes, C-reactive protein,      Interleukin-6, procalcitonin) fever (> 38,5\u00b0C longer than 2 days)", 
                "measure": "safety", 
                "safety_issue": "Yes", 
                "time_frame": "week 12 post surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02153372"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Goethe University", 
            "investigator_full_name": "Ingo Marzi, MD Prof.", 
            "investigator_title": "head physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Analysis of feasibility  of isolation and application of BMC, logistic and clinical controls", 
                "measure": "feasibility", 
                "safety_issue": "No", 
                "time_frame": "at day-1"
            }, 
            {
                "description": "Analysis of feasibility  of isolation and application of BMC, logistic and clinical controls", 
                "measure": "feasibility", 
                "safety_issue": "No", 
                "time_frame": "at day 0"
            }, 
            {
                "description": "Analysis of feasibility  of isolation and application of BMC, logistic and clinical controls", 
                "measure": "feasibility", 
                "safety_issue": "No", 
                "time_frame": "week 1 post surgery"
            }, 
            {
                "description": "Analysis of feasibility  of isolation and application of BMC, logistic and clinical controls", 
                "measure": "feasibility", 
                "safety_issue": "No", 
                "time_frame": "week 6 post surgery"
            }, 
            {
                "description": "Analysis of feasibility  of isolation and application of BMC, logistic and clinical controls", 
                "measure": "feasibility", 
                "safety_issue": "No", 
                "time_frame": "week 12 post surgery"
            }
        ], 
        "source": "Goethe University", 
        "sponsors": {
            "collaborator": {
                "agency": "ProLOEWE, Germany", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Goethe University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}